Amgen
Patents, Design & Utilities
Last updated:
List of all Amgen patents 684 in total
| Status | Patent |
|---|---|
Grant | Utility: Systems and approaches for sterilizing a drug delivery device Filling date: 6 Sep 2025 Issue date: 19 Apr 2022 |
Grant | Utility: Needle insertion-retraction system having dual torsion spring system Filling date: 6 Sep 2025 Issue date: 19 Apr 2022 |
Grant | Utility: Compounds that inhibit MCL-1 protein Filling date: 6 Sep 2025 Issue date: 19 Apr 2022 |
Application | Utility: HUMAN CD30 LIGAND ANTIGEN BINDING PROTEINS Filling date: 6 Sep 2025 Issue date: 14 Apr 2022 |
Grant | Utility: Use of monensin to regulate glycosylation of recombinant proteins Filling date: 6 Sep 2025 Issue date: 12 Apr 2022 |
Grant | Utility: Bisamide sarcomere activating compounds and uses thereof Filling date: 6 Sep 2025 Issue date: 12 Apr 2022 |
Grant | Utility: Method of assembling and filling a drug delivery device Filling date: 6 Sep 2025 Issue date: 12 Apr 2022 |
Grant | Utility: Synthesis of key intermediate of KRAS G12C inhibitor compound Filling date: 6 Sep 2025 Issue date: 12 Apr 2022 |
Application | Utility: SOLID STATE FORMS Filling date: 6 Sep 2025 Issue date: 7 Apr 2022 |
Application | Utility: KIF18A INHIBITORS Filling date: 6 Sep 2025 Issue date: 7 Apr 2022 |
Application | Utility: ALTERNATE DETERGENTS FOR VIRAL INACTIVATION Filling date: 6 Sep 2025 Issue date: 7 Apr 2022 |
Grant | Utility: Method for using light scattering in real time to directly monitor and control impurity removal in purification processes Filling date: 6 Sep 2025 Issue date: 5 Apr 2022 |
Application | Utility: AUTOMATED DRUG DELIVERY DEVICE AND CONTAINER Filling date: 6 Sep 2025 Issue date: 31 Mar 2022 |
Application | Utility: CONTINUOUS DOSING SYSTEMS AND APPROACHES Filling date: 6 Sep 2025 Issue date: 31 Mar 2022 |
Application | Utility: AFLIBERCEPT ATTRIBUTES AND METHODS OF CHARACTERIZING AND MODIFYING THEREOF Filling date: 6 Sep 2025 Issue date: 31 Mar 2022 |
Grant | Utility: KRAS G12C inhibitors and methods of using the same Filling date: 6 Sep 2025 Issue date: 29 Mar 2022 |
Grant | Utility: Substituted piperazines as KRAS G12C inhibitors Filling date: 6 Sep 2025 Issue date: 29 Mar 2022 |
Grant | Utility: Drug delivery device having minimized risk of component fracture upon impact events Filling date: 6 Sep 2025 Issue date: 29 Mar 2022 |
Application | Utility: VARIANTS OF TISSUE INHIBITOR OF METALLOPROTEINASE TYPE THREE (TIMP-3), COMPOSITIONS AND METHODS Filling date: 6 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: USE OF ONCOLYTIC VIRUSES FOR THE TREATMENT OF CANCER Filling date: 6 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: SYSTEMS AND APPROACHES FOR DRUG DELIVERY DEVICE RECONSTITUTION Filling date: 6 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: BISPECIFIC ANTIBODIES WITH CLEAVABLE C-TERMINAL CHARGE-PAIRED TAGS Filling date: 6 Sep 2025 Issue date: 24 Mar 2022 |
Grant | Utility: Macrocyclic compounds that inhibit MCL-1 protein Filling date: 6 Sep 2025 Issue date: 22 Mar 2022 |
Application | Utility: METHODS FOR INCREASING MANNOSE CONTENT OF RECOMBINANT PROTEINS Filling date: 6 Sep 2025 Issue date: 17 Mar 2022 |
Grant | Utility: Injector and method of assembly Filling date: 6 Sep 2025 Issue date: 15 Mar 2022 |
Grant | Utility: Alpha-hydroxy phenylacetic acid pharmacophore or bioisostere Mcl-1 protein antagonists Filling date: 6 Sep 2025 Issue date: 15 Mar 2022 |
Grant | Utility: Quantitation of glycan moiety in recombinant glycoproteins Filling date: 6 Sep 2025 Issue date: 15 Mar 2022 |
Application | Utility: CONTINUOUS DOSING SYSTEMS AND APPROACHES Filling date: 6 Sep 2025 Issue date: 10 Mar 2022 |
Application | Utility: KIF18A INHIBITORS Filling date: 6 Sep 2025 Issue date: 10 Mar 2022 |
Grant | Utility: Modified Fc molecules Filling date: 6 Sep 2025 Issue date: 8 Mar 2022 |
Grant | Utility: Crystalline antibody formulations Filling date: 6 Sep 2025 Issue date: 8 Mar 2022 |
Grant | Utility: Antibodies directed to HER-3 and uses thereof Filling date: 6 Sep 2025 Issue date: 8 Mar 2022 |
Grant | Utility: Drug delivery device, method of manufacture, and method of use Filling date: 6 Sep 2025 Issue date: 8 Mar 2022 |
Application | Utility: BINDING MOLECULES FOR BCMA AND CD3 Filling date: 6 Sep 2025 Issue date: 3 Mar 2022 |
Application | Utility: CONTINUOUS DOSING SYSTEMS AND APPROACHES Filling date: 6 Sep 2025 Issue date: 3 Mar 2022 |
Application | Utility: MUTATED PIGGYBAC TRANSPOSASE Filling date: 6 Sep 2025 Issue date: 3 Mar 2022 |
Grant | Utility: (+)-2-[1-(3-Ethoxy-4- methoxyphenyl)-2-methylsulfonylethyl]- 4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof Filling date: 6 Sep 2025 Issue date: 1 Mar 2022 |
Application | Utility: HUMAN IL-23 ANTIGEN BINDING PROTEINS Filling date: 6 Sep 2025 Issue date: 24 Feb 2022 |
Application | Utility: DRUG DELIVERY DEVICE AND METHOD Filling date: 6 Sep 2025 Issue date: 24 Feb 2022 |
Application | Utility: KIF18A INHIBITORS Filling date: 6 Sep 2025 Issue date: 24 Feb 2022 |
Application | Utility: SHEET LIGHTING FOR PARTICLE DETECTION IN DRUG PRODUCT CONTAINERS Filling date: 6 Sep 2025 Issue date: 24 Feb 2022 |
Grant | Utility: Bisamide sarcomere activating compounds and uses thereof Filling date: 6 Sep 2025 Issue date: 22 Feb 2022 |
Grant | Utility: Increasing ornithine accumulation to increase high mannose glycoform content of recombinant proteins Filling date: 6 Sep 2025 Issue date: 22 Feb 2022 |
Application | Utility: RNAi CONSTRUCTS AND METHODS FOR INHIBITING MARC1 EXPRESSION Filling date: 6 Sep 2025 Issue date: 17 Feb 2022 |
Application | Utility: MODULAR FLUID PATH ASSEMBLIES FOR DRUG DELIVERY DEVICES Filling date: 6 Sep 2025 Issue date: 17 Feb 2022 |
Application | Utility: CHEMICALLY-MODIFIED RNAi CONSTRUCTS AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 17 Feb 2022 |
Application | Utility: PURIFICATION METHODS FOR GUANINE-RICH OLIGONUCLEOTIDES Filling date: 6 Sep 2025 Issue date: 17 Feb 2022 |
Grant | Utility: Methods for treating a headache condition using anti-human PAC1 antibodies or antigen-binding fragments thereof Filling date: 6 Sep 2025 Issue date: 15 Feb 2022 |
Grant | Utility: Antigen binding proteins that bind to a complex comprising .beta.-Klotho and an FGF receptor Filling date: 6 Sep 2025 Issue date: 15 Feb 2022 |
Application | Utility: STABLE LIQUID FORMULATION OF AMG 416 (ETELCALCETIDE) Filling date: 6 Sep 2025 Issue date: 10 Feb 2022 |
Showing 100 to 150 of 684 patents.